Krystal Biotech (KRYS) Stock Looks Overvalued After A 7x Run

Krystal Biotech has produced a very large 5 year share price gain, which naturally puts the focus on whether that move is supported by the business it has built. With the stock now trading around US$324.57, the practical question for you is how well that market value lines up with the earnings the company is generating. A roughly 7x return over 5 years puts a lot of expectations into the price. The key issue is how firmly those expectations rest on current and future earnings power. The...